Skip to main content
Top
Published in: Supportive Care in Cancer 5/2009

01-05-2009 | Short Communication

Prognostic implications of emergency admission and delays in patients with breast cancer

Authors: Maximino Redondo, Isabel Rodrigo, Teresa Pereda, Rafael Funez, Mercedes Acebal, Emilio Perea-Milla, Eugenio Jimenez

Published in: Supportive Care in Cancer | Issue 5/2009

Login to get access

Abstract

Introduction

This study evaluates clinical–pathological characteristics and survival rates associated with emergency admission and delays in diagnosis and treatment of 411 consecutive breast cancer patients.

Materials and methods

Emergency admission and first symptom–first hospital visit delay were significantly associated with advanced tumor stages but only in the former case with short disease-free survival (RR 2.5, CI 95% 1.5–4.2).

Results

Brief diagnostic delays were significantly associated with advanced disease stage and poor survival rates (RR 2.04; CI 95% 1.08–3.82) probably because sicker patients receive prompt medical attention.
Literature
1.
go back to reference Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D et al (2002) The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 325:196 doi:10.1136/bmj.325.7357.196 PubMedCrossRef Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D et al (2002) The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ 325:196 doi:10.​1136/​bmj.​325.​7357.​196 PubMedCrossRef
2.
go back to reference Elwood JM, Moorehead WP (1980) Delay in diagnosis and long-term survival in breast cancer. BMJ 280:1291–1294PubMedCrossRef Elwood JM, Moorehead WP (1980) Delay in diagnosis and long-term survival in breast cancer. BMJ 280:1291–1294PubMedCrossRef
4.
go back to reference Maguire A, Porta M, Malats N, Gallen M, Piñol JL, Fernandez E (1994) Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer 30A:785–792 doi:10.1016/0959-8049(94)90293-3 PubMedCrossRef Maguire A, Porta M, Malats N, Gallen M, Piñol JL, Fernandez E (1994) Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. ISDS II Project Investigators. Eur J Cancer 30A:785–792 doi:10.​1016/​0959-8049(94)90293-3 PubMedCrossRef
5.
go back to reference Myrdal G, Lambe M, Hillerdal G, lamberg K, Augustsson T, Stahle E (2004) Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 59:45–49PubMed Myrdal G, Lambe M, Hillerdal G, lamberg K, Augustsson T, Stahle E (2004) Effect of delays on prognosis in patients with non-small cell lung cancer. Thorax 59:45–49PubMed
6.
go back to reference Pollock AM, Vickers N (1998) Deprivation and emergency admissions for cancers of colorectum, lung, and breast in south east England: ecological study. BMJ 317:245–252PubMed Pollock AM, Vickers N (1998) Deprivation and emergency admissions for cancers of colorectum, lung, and breast in south east England: ecological study. BMJ 317:245–252PubMed
7.
go back to reference Porta M, Fernandez E, Belloc J, Malats N, Gallen M, Alonso J (1998) Emergency admission for cancer: a matter of survival? Br J Cancer 77:477–484PubMed Porta M, Fernandez E, Belloc J, Malats N, Gallen M, Alonso J (1998) Emergency admission for cancer: a matter of survival? Br J Cancer 77:477–484PubMed
8.
go back to reference Redondo M, Rivas F, Guzmán MC, Labajos C (2008) Monitoring indicators of healthcare quality by means of a hospital register of tumors. J Eval Clin Pract (in press) Redondo M, Rivas F, Guzmán MC, Labajos C (2008) Monitoring indicators of healthcare quality by means of a hospital register of tumors. J Eval Clin Pract (in press)
Metadata
Title
Prognostic implications of emergency admission and delays in patients with breast cancer
Authors
Maximino Redondo
Isabel Rodrigo
Teresa Pereda
Rafael Funez
Mercedes Acebal
Emilio Perea-Milla
Eugenio Jimenez
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 5/2009
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0513-2

Other articles of this Issue 5/2009

Supportive Care in Cancer 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine